# Mitobridge

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mitobridge

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.mitobridge.com
- Total disclosed funding: $5.2M
- Latest round: Series A (Oct 17, 2013)
- Investors on record: 3

## About

Founded in 2011 and based in Massachusetts, US, Mitobridge, Inc., is a biopharmaceutical company that develops small molecule therapeutics to improve mitochondrial functions and to treat diseases with a high unmet medical need.

## Funding rounds

- Series A, Oct 17, 2013, $5.2M — MPM BioImpact, Longwood Fund, Astellas Pharma Inc.

## Investors

- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A
- Longwood Fund (https://capitalatlas.ai/funds/longwood-fund) — Series A
- Astellas Pharma Inc. — Series A